0.9% Sodium Chloride Injection, 10mL and 2 more items

The University of Virginia awarded contract A207_PO-0450261-V3 to MWI Animal Health on August 8, 2026, for the supply of veterinary pharmaceuticals and medical solutions. The contract, valued at fifty-nine dollars ($59), encompasses three distinct pharmaceutical line items: 0.9% Sodium Chloride Injection in 10 milliliter quantities (31 boxes), Ketamine Hydrochloride Injection 100 milligrams per milliliter (7 bottles), and Rompun (Xylazine) Injectable in 50 milliliter bottles (20 bottles). All deliveries are designated to the buyer, the University of Virginia.

MWI Animal Health will supply these pharmaceuticals to support the University of Virginia's veterinary and animal health operations in Virginia. The contract line items indicate procurement of injectable sedatives, analgesics, and saline solutions commonly utilized in veterinary medical practice. The minimal contract value and unit pricing structure suggest this represents a routine purchase order for standard veterinary pharmaceutical supplies rather than a comprehensive service agreement. No specific performance period beyond the award date of August 8, 2026, is identified in the contract documentation.